AtriCure (ATRC) Receivables (2010 - 2026)

AtriCure (ATRC) has 17 years of Receivables data on file, last reported at $71.3 million in Q1 2026.

• Receivables for Q1 2026 came in at $71.3 million, up 12.62% year-over-year; the trailing twelve-month figure through Mar 2026 was $71.3 million (up 12.62% YoY), and the FY2025 annual result was $66.7 million, up 10.46% from the prior year.
• Receivables climbed to $71.3 million in Q1 2026 per ATRC's latest filing, from $66.7 million in the prior quarter.
• Over five years, Receivables peaked at $71.3 million in Q1 2026 and troughed at $40.9 million in Q1 2022.
• A 5-year average of $54.2 million and a median of $54.9 million in 2024 frame the typical range for Receivables.
• The sharpest annual moves came in 2022 and 2024: Receivables jumped 37.45% in 2022, then climbed 6.56% in 2024.
• A 5-year view of Receivables shows it stood at $42.7 million in 2022, then advanced by 22.97% to $52.5 million in 2023, then rose by 14.93% to $60.3 million in 2024, then advanced by 10.46% to $66.7 million in 2025, then grew by 6.99% to $71.3 million in 2026.
• Business Quant data shows ATRC's Receivables at $71.3 million in Q1 2026, $66.7 million in Q4 2025, and $63.0 million in Q3 2025.